The ongoing opioid crisis in the U.S. is harrowing – 91 Americans die every day from an opioid overdose, according to the Centers for Disease Control & Prevention. Companies are searching for innovative ways to deliver opioid maintenance treatment to patients that are hoping to get clean. Buprenorphine is a compound used for medication-assisted treatment, traditionally administered as a tablet or a patch. When Titan Pharmaceuticals (NSDQ:TTNP) began early testing of its buprenorphine implant, patients were eager to get their hands on the product. “More than 80% of the patients who completed the first 6 months wanted to enroll in the second 6 months,” CEO Sunil Bhonsle told Drug Delivery Business News. Get the full story at our sister site, Drug Delivery Business New...
from MedWorm: AddictionNews https://medworm.com/index.php?rid=299005462&cid=d_2_23_f&fid=39396&url=http%3A%2F%2Fwww.massdevice.com%2Ftitan-pharmaceuticals-match-sized-implant-fights-back-opioid-addiction%2F
No comments:
Post a Comment